Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas

European Journal of Endocrinology

Volumn 163, Issue 4, 2010, Pages 523-529

  Tani, Yuji ^a   Inoshita, Naoko ^b   Sugiyama, Toru ^a   Kato, Masako ^a   Yamada, Shozo ^b   Shichiri, Masayoshi ^c   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUB1 RELATED PROTEIN; CYCLIN A1; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2;

ACTH SECRETING ADENOMA; ADULT; ARTICLE; CELL CYCLE REGULATION; CLINICAL ARTICLE; CUSHING DISEASE; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTH-SECRETING PITUITARY ADENOMA; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957105235     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0245     Document Type: Article

References (32)

1. Boscaro M, Barzon L, Fallo F & Sonino N. Cushing's syndrome. Lancet 2001 357 783-791. (doi:10.1016/S0140-6736(00)04172-6)
2. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME & Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. American Journal of Pathology 1980 98 617-638. (Pubitemid 10154792)
3. Harbour JW & Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes and Development 2000 14 2393-2409. (doi:10.1101/gad.813200)
4. 1-phase progression. Genes and Development 1999 13 1501-1512. (doi:10.1101/gad.13.12.1501)
5. Serrano M, Hannon GJ & Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993 366 704-707. (doi:10.1038/366704a0)
6. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB & Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine 1995 1 686-692. (doi:10.1038/nm0795-686)
7. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D & Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research 1995 55 4525-4530.
8. 1 arrest in the AtT20 pituitary tumor cell line. Molecular Endocrinology 1999 13 1801-1810. (doi:10.1210/me.13.11.1801)
9. Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. International Journal of Cancer 1995 61 115-120. (doi:10.1002/ijc.2910610120)
10. Szijan I, Orlow I, Dalamon V, Vergani P, Danilowicz K, Mezzadri N, Cordon-Cardo C & Bruno OD. Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors. Oncology Reports 2000 7 421-425.
11. Malumbres M & Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nature Reviews. Cancer 2001 1 222-231. (doi:10.1038/ 35106065)
12. Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T & Fukushima T. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas. Journal of Neuro-Oncology 2007 83 153-162. (doi:10.1007/s11060-006-9316-9)
13. Simpson DJ, Frost SJ, Bicknell JE, Broome JC, McNicol AM, Clayton RN & Farrell WE. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas. Carcinogenesis 2001 22 1149-1154. (doi:10.1093/carcin/22.8.1149)
14. Musat M, Morris DG, Korbonits M & Grossman AB. Cyclins and their related proteins in pituitary tumourigenesis. Molecular and Cellular Endocrinology, 2010. (doi:10.1016/j.mce.2010.03.017)
15. Kovacs K, Horvath E, Bayley TA, Hassaram ST & Ezrin C. Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. American Journal of Medicine 1978 64 492-499. (doi:10.1016/0002-9343(78)90236-X) (Pubitemid 8302308)
16. Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S & Hirata Y. Differential gene expression in ACTH-secreting and non-functioning pituitary tumors. European Journal of Endocrinology 2007 157 717-724. (doi:10.1530/EJE-07-0428)
17. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K & Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Research 2002 62 13-17.
18. INK4a gene product in human pituitary tumors. Cancer Research 1996 56 2493-2496.
19. Jordan S, Lidhar K, Korbonits M, Lowe DG & Grossman AB. Cyclin D and cyclin E expression in normal and adenomatous pituitary. European Journal of Endocrinology 2000 143 R1-R6. (doi:10.1530/eje.0.143R001)
20. Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, Clayton RN & Farrell WE. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clinical Cancer Research 1999 5 2133-2139.
21. Quereda V & Malumbres M. Cell cycle control of pituitary development and disease. Journal of Molecular Endocrinology 2009 42 75-86. (doi:10.1677/JME-08-0146)
22. Simpson DJ, Bicknell JE, McNicol AM, Clayton RN & Farrell WE. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes, Chromosomes and Cancer 1999 24 328-336. (doi:10.1002/(SICI)1098-2264 (199904)24:4〈328::AID-GCC6〉3.0.CO;2-P)
23. Machiavelli G, Cotignola J, Danilowicz K, Carbonara C, Paes de Lima A, Basso A, Bruno OD & Szijan I. Expression of p16(INK4A) gene in human pituitary tumours. Pituitary 2008 11 71-75. (doi:10.1007/s11102-007-0077-z)
24. Seemann N, Kuhn D, Wrocklage C, Keyvani K, Hackl W, Buchfelder M, Fahlbusch R & Paulus W. CDKN2A/p16 inactivation is related to pituitary adenoma type and size. Journal of Pathology 2001 193 491-497. (doi:10.1002/path.833)
25. Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T & Fukushima T. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. Journal of Neuropathology and Experimental Neurology 2005 64 398-403.
26. 1 control. Cancer Research 1995 55 4818-4823.
27. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF & Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Research 1995 55 1613-1616.
28. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN & Farrell WE. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Research 2000 60 1211-1216.
29. van Wijk PA, van Neck JW, Rijnberk A, Croughs RJ & Mol JA. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Molecular and Cellular Endocrinology 1995 111 13-19. (doi:10.1016/0303-7207(95)03541-E)
30. Kooistra HS, Voorhout G, Mol JA & Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Journal of Endocrinology 1997 152 387-394. (doi:10.1677/joe.0.1520387) (Pubitemid 27102203)
31. Gotoh T, Chowdhury S, Takiguchi M & Mori M. The glucocorticoid- responsive gene cascade. Activation of the rat arginase gene through induction of C/EBPbeta. Journal of Biological Chemistry 1997 272 3694-3698. (doi:10.1074/jbc.272.30.18602)
32. Reisman D & Thompson EA. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells. Molecular Endocrinology 1995 9 1500-1509. (doi:10.1210/me.9.11.1500)